This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: MediPharm Labs Corp.
Announced the closing of the sale of its Hope, British Columbia facility to Rubicon Organics Inc. for $4.5 million in cash. In parallel, the Company is expanding annual international cultivation capacity at its EU GMP-certified facility in Napanee, Ontario by approximately 30% in 2025. MediPharm Labs Corp. shares T.LABS are trading down $0.01 at $0.07.
